Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (41-50 of 418) with videos related to

Pageof 42
Sort By:
Cutis|August 21, 2008
A new standardized method of evaluating cutaneous irritation from topical medicationsAnnemarie Uliasz, Mark Lebwohl
Journal of the American Academy of Dermatology|October 25, 2003
Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagenHassan Galadari, Mark Lebwohl
Cutis|July 28, 2006
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl, Lisa G Herrmann
Journal of Drugs in Dermatology : JDD|July 10, 2003
Treatment of mycosis fungoides with oral bexarotene combined with PUVADana Kaslow Stern, Mark Lebwohl
Dermatologic Clinics|April 14, 2007
Potential complications associated with the use of biologic agents for psoriasisJoshua A Zeichner, Mark Lebwohl
Annals of Internal Medicine|August 4, 2011
In the clinic. PsoriasisRita V Patel, Mark Lebwohl
Cutis|December 25, 2007
The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasisMark Lebwohl, Luz E Colón
Journal of the American Academy of Dermatology|February 13, 2023
Response to comment on the article entitled "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study"Mindy Kresch-Vatch, Mark Lebwohl
Clinics in Dermatology|October 22, 2011
Iatrogenic effects of biologics for psoriasisMary L Stevenson, Mark Lebwohl
Clinics in Dermatology|June 5, 2003
Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndromeMarvin J Rapaport, Mark Lebwohl
Pageof 42

Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Cutis|August 21, 2008
A new standardized method of evaluating cutaneous irritation from topical medicationsAnnemarie Uliasz, Mark Lebwohl
Journal of the American Academy of Dermatology|October 25, 2003
Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagenHassan Galadari, Mark Lebwohl
Cutis|July 28, 2006
Impaired skin barrier function in dermatologic disease and repair with moisturizationMark Lebwohl, Lisa G Herrmann
Journal of Drugs in Dermatology : JDD|July 10, 2003
Treatment of mycosis fungoides with oral bexarotene combined with PUVADana Kaslow Stern, Mark Lebwohl
Dermatologic Clinics|April 14, 2007
Potential complications associated with the use of biologic agents for psoriasisJoshua A Zeichner, Mark Lebwohl
Annals of Internal Medicine|August 4, 2011
In the clinic. PsoriasisRita V Patel, Mark Lebwohl
Cutis|December 25, 2007
The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasisMark Lebwohl, Luz E Colón
Journal of the American Academy of Dermatology|February 13, 2023
Response to comment on the article entitled "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study"Mindy Kresch-Vatch, Mark Lebwohl
Clinics in Dermatology|October 22, 2011
Iatrogenic effects of biologics for psoriasisMary L Stevenson, Mark Lebwohl
Clinics in Dermatology|June 5, 2003
Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndromeMarvin J Rapaport, Mark Lebwohl
Pageof 42